Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-015693
Filing Date
2025-02-06
Accepted
2025-02-06 20:08:43
Documents
1
Period of Report
2025-02-04

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5738
  Complete submission text file 0000950170-25-015693.txt   7295
Mailing Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 901 BOSTON MA 02215 (857) 320-4900
Tango Therapeutics, Inc. (Issuer) CIK: 0001819133 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C4 THERAPEUTICS, INC. 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address
Crystal Adam (Reporting) CIK: 0001825445 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39485 | Film No.: 25598880